AOD 9604, a synthetic fragment of growth hormone, has emerged as a potential therapeutic agent for achieving fat loss. This peptide exerts its effects by targeting lipid stores, promoting the breakdown of triglycerides and reducing lipogenesis, the process of fat formation. Preclinical studies have demonstrated AOD 9604's ability to specifically ad

When seeking a reliable partner for your peptide development journey in the United States, look no further than [Company Name]. As a leading CDMO specializing in peptides, we provide comprehensive capabilities from research and development to GMP manufacturing. Our commitment to quality is unwavering, ensuring all our peptides meet the stringent sp